ArticleCommunications biology2025
Ammonia reduces glutamine synthetase expression in astrocytes via activation of Hippo-YAP signaling pathways.
Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Glutamine metabolism in health and disease.Signal transduction and targeted therapy · 2026Review
- Article
- Adiponectin Inhibits Oxidative Stress and Tight Junction Protein Loss: Evidence from a Hepatic Encephalopathy Mouse Model and Brain Endothelial Cells.Pharmaceuticals (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Glutamine synthetase (GS) expressed in astrocytes plays an important role in maintaining the amount of extracellular glutamate and ammonia in the brain. Deficiency of GS is associated with several neurological disorders including epilepsy, but the molecular mechanism underlying the control of GS expression and the mechanism of GS reduction in diseased brain remain elusive. Here we show that in astrocytes, GS level is regulated by a transcription coactivator YAP via two signaling pathways, the Hippo and Wnt/β-catenin pathways. But when the extracellular glutamate and ammonia are increased, ammonia inhibits YAP nuclear localization through Hippo pathways and reduces GS. Using rodent models of epilepsy, we found that the induction of YAP nuclear translocation with Hippo kinase inhibitor XMU-MP-1 suppresses GS downregulation and protects neurons against cell death. Our work identifies that YAP may become an effective target for diseases in which astrocytic GS is reduced due to elevated ammonia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.